SCHEMBL30867498

SCHEMBL30867498

COC(=O)c1c(F)cc(C(F)(F)F)c(N)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 7/20 0.44
NOTUM Q6P988 3/20 0.40
CISD2 Q8N5K1 2/20 0.39
MAPT P10636 1/20 0.36
CYP3A4 P08684 1/20 0.35
ACHE P22303 1/20 0.35
GRM6 O15303 1/20 0.35
GRM5 P41594 1/20 0.35
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34
GABRB2 P47870 1/20 0.34
GABRA4 P48169 1/20 0.34
GABRE P78334 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25174744 1.00 CFTR (0.44) CFTRNOTUMCISD2MAPTCYP3A4
SCHEMBL25187347 0.84 NOTUM (0.46) CFTRNOTUMMAPTGABRPGABRD
SCHEMBL26121563 0.83 KDM4E (0.33) CFTRNOTUMGRM5AR
SCHEMBL30634617 0.83 KDM4E (0.33) CFTRNOTUMGRM5AR
SCHEMBL25201237 0.82 NOTUM (0.40) CFTRNOTUMCISD2MAPTCYP3A4
SCHEMBL25180891 0.82 SOS1 (0.46) CFTRNOTUMCISD2CYP3A4ACHE
SCHEMBL30867275 0.82 NOTUM (0.40) CFTRNOTUMMAPTCYP3A4ACHE
SCHEMBL29090594 0.82 NOTUM (0.40) CFTRNOTUMMAPTCYP3A4ACHE
SCHEMBL22208636 0.81 NOTUM (0.42) CFTRNOTUMCISD2MAPTCYP3A4
SCHEMBL18985227 0.78 LMNA (0.41) NOTUMCISD2CYP3A4ACHEGRM6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583867-A2 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE Latigo Biotherapeutics, Inc. (US) 2025-07-16 EP disclosed
WO-2024054622-A2 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE LATIGO BIOTHERAPEUTICS, INC. (US) 2024-03-14 WO disclosed